214 related articles for article (PubMed ID: 10629658)
1. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
3. Contribution of 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy.
Carril JM; Gómez-Barquín R; Quirce R; Tabuenca O; Uriarte I; Montero A
Anticancer Res; 1997; 17(3B):1677-81. PubMed ID: 9179217
[TBL] [Abstract][Full Text] [Related]
4. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
6. Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions.
Uriarte I; Carril JM; Quirce R; Gutiérrez-Mendiguchía C; Blanco I; Banzo I; Vega A; Hernández A
Eur J Nucl Med; 1998 May; 25(5):491-6. PubMed ID: 9575244
[TBL] [Abstract][Full Text] [Related]
7. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
[TBL] [Abstract][Full Text] [Related]
8. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H
Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer.
Piccolo S; Lastoria S; Mainolfi C; Muto P; Bazzicalupo L; Salvatore M
J Nucl Med; 1995 May; 36(5):718-24. PubMed ID: 7738640
[TBL] [Abstract][Full Text] [Related]
10. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses.
Lee JK; Kao CH; Sun SS
Oncol Rep; 1999; 6(3):659-63. PubMed ID: 10203611
[TBL] [Abstract][Full Text] [Related]
12. (99)mTc-3PRGD2 scintimammography in palpable and nonpalpable breast lesions.
Liu L; Song Y; Gao S; Ji T; Zhang H; Ji B; Chen B; Jia B; Wang F; Xu Z; Ma Q
Mol Imaging; 2014; 13(5):. PubMed ID: 24825112
[TBL] [Abstract][Full Text] [Related]
13. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.
Palmedo H; Grünwald F; Bender H; Schomburg A; Mallmann P; Krebs D; Biersack HJ
Eur J Nucl Med; 1996 Aug; 23(8):940-6. PubMed ID: 8753683
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of technetium-99m tetrofosmin scintimammography to detect breast cancer in mammographically dense breasts.
Yang MD; Sun SS; Kao CH; Lin CC; Lee CC
Cancer Invest; 2002; 20(4):518-23. PubMed ID: 12094547
[TBL] [Abstract][Full Text] [Related]
15. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
[TBL] [Abstract][Full Text] [Related]
16. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.
Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M
Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879
[TBL] [Abstract][Full Text] [Related]
17. 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis.
Turhal NS; Dane F; Dede F; Gumus M; Yumuk PF; Cakalagaoglu F; Savci D; Karaman M; Gulluoglu B; Turoglu HT
Anticancer Res; 2004; 24(3b):1999-2006. PubMed ID: 15274391
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging.
Ozülker T; Ozülker F; Ozpaçaci T; Bender O; Değirmenci H
Hell J Nucl Med; 2010; 13(2):144-9. PubMed ID: 20808988
[TBL] [Abstract][Full Text] [Related]
19. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
20. Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammographically dense breast.
Wang HC; Sun SS; Kao A; Lin CC; Lee CC
Cancer Invest; 2002; 20(3):318-23. PubMed ID: 12025226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
